Synaptogenix, Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported net loss was USD 12.61 million compared to USD 12.7 million a year ago. Basic loss per share from continuing operations was USD 2.51 compared to USD 12.03 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.51 USD | -3.63% | -5.05% | -33.65% |
04-09 | Synaptogenix, Inc. acquired Unknown Stake in Psyga Bio Ltd from Cannasoul Analytics Ltd. | CI |
04-03 | Synaptogenix Plans 1-for-25 Reverse Stock Split; Shares Fall | MT |
1st Jan change | Capi. | |
---|---|---|
-33.65% | 4.89M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- SNPX Stock
- News Synaptogenix, Inc.
- Synaptogenix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021